SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-136259
Filing Date
2024-05-10
Accepted
2024-05-10 16:57:37
Documents
12
Effectiveness Date
2024-05-10

Document Format Files

Seq Description Document Type Size
1 S-3ASR d801219ds3asr.htm S-3ASR 396149
2 EX-1.3 d801219dex13.htm EX-1.3 12144
3 EX-4.2 d801219dex42.htm EX-4.2 265578
4 EX-4.3 d801219dex43.htm EX-4.3 278759
5 EX-5.1 d801219dex51.htm EX-5.1 16169
6 EX-5.2 d801219dex52.htm EX-5.2 9137
7 EX-23.1 d801219dex231.htm EX-23.1 2442
8 EX-FILING FEES d801219dexfilingfees.htm EX-FILING FEES 91384
9 GRAPHIC g801219g00a01.jpg GRAPHIC 28220
10 GRAPHIC g801219g0229074057790.jpg GRAPHIC 2654
11 GRAPHIC g801219g0229074443542.jpg GRAPHIC 2654
12 GRAPHIC g801219g35o87.jpg GRAPHIC 23363
  Complete submission text file 0001193125-24-136259.txt   1148328
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-279338 | Film No.: 24935803
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)